Capital Flow Monitor · Sponsors · CIK 2139579
Affinity Healthcare Strategic Opportunities Fund, LP
450 PARK AVENUE - SUITE 1403, NEW YORK, NY, 10022 · 646-481-3856
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
—
Sold
$59.7M
% sold
—
Investors
52
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | D/A ·current | 506(b) | — | $59.7M | — | 52 | EDGAR ↗ |
| 2026-06-16 | D | 506(b) | — | $59.7M | — | 52 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Michael Cho — Executive Officer / Director, New York, NY
3 other raises
- Affinity Healthcare Offshore Fund, Ltd. $222.2M of —
- Affinity Healthcare Fund, LP $409.1M of —
- LeadScorz Inc. $150K of $1.5M · 10.0%
- Michael Baran — Executive Officer / Director, New York, NY
- Patrick Nosker — Executive Officer / Director, New York, NY
-
Andrew Weinstein — Executive Officer, New York, NY
3 other raises
- Affinity Healthcare Offshore Fund, Ltd. $222.2M of —
- Affinity Healthcare Fund, LP $409.1M of —
- Fintex Group, Inc. $5.0M of $30.0M · 16.7%
- N/A Affinity Healthcare Strategic Opportunities GP, LLC — Promoter, New York, NY
- N/A Affinity Private Strategies LP — Promoter, New York, NY
- N/A Affinity Private Strategies GP LLC — Promoter, New York, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.